Straitstimes.com header logo

Choose edition

Search

singapore

asia

world

opinion

life

business

sport

Visual

Podcasts

STClassifieds

Paid press releases

Advertise with us

FAQs

Contact us

 

Obesity

Sponsored Content

Your body is fighting your diet – here’s the science that explains why

obesity treatment, weight loss challenges, metabolic health
obesity treatment, weight loss challenges, metabolic health

Asian Insider

Battling the bulge jab by jab: India’s weight-loss drugs now within the reach of millions

Bengaluru-based food consultant Monika Manchanda, 50, spoke of the weight loss drug as offering a mental break from a years-long worry.
Bengaluru-based food consultant Monika Manchanda, 50, spoke of the weight loss drug as offering a mental break from a years-long worry.

Vietnam’s weight problem grows as prosperity reshapes diets and lifestyles

Without early intervention, obesity could cost Vietnam up to US$16.28 billion (S$21 billion) by 2035, or about 2 per cent of GDP.
Without early intervention, obesity could cost Vietnam up to US$16.28 billion (S$21 billion) by 2035, or about 2 per cent of GDP.

GLP-1 drugs may have a beneficial effect across many types of cancer

FILE PHOTO: A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo
FILE PHOTO: A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo

France to reimburse cost of weight-loss drugs for severely obese patients

Boxes of Wegovy move along a packaging line at Novo Nordisk's facility in Hillerod, Denmark, March 8, 2024. REUTERS/ Tom Little
Boxes of Wegovy move along a packaging line at Novo Nordisk's facility in Hillerod, Denmark, March 8, 2024. REUTERS/ Tom Little

Fatty liver genes combined with diabetes and obesity increase liver cancer risk: S’pore study

Adj A/Prof Daniel Huang, Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, NUH and Chair of the Hepato-Pancreato-Biliary Cancer Programme at NCIS, with his patient Mr Foo Say Nong at NUH Medical Centre on May 25, 2026.
Adj A/Prof Daniel Huang, Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, NUH and Chair of the Hepato-Pancreato-Biliary Cancer Programme at NCIS, with his patient Mr Foo Say Nong at NUH Medical Centre on May 25, 2026.

Pop pill to lose weight? The GLP-1 ‘magic bullet’ is enticing – and dangerous

Like antibiotics, the weight loss drugs are at risk of being misused.
Like antibiotics, the weight loss drugs are at risk of being misused.

Germany to impose levy on sugary drinks in bid to reduce obesity rates

The move comes as Germany aims to rein in rising rates of obesity to ease pressure on the health system.
The move comes as Germany aims to rein in rising rates of obesity to ease pressure on the health system.

Chinese slimmers trade lost fat for beef

More than a third of Chinese adults were overweight in 2022, and around 8.3 per cent were obese, according to the World Health Organization.
More than a third of Chinese adults were overweight in 2022, and around 8.3 per cent were obese, according to the World Health Organization.

Growing number of liver transplant patients linked to obesity and diabetes, instead of hepatitis B

Lian Pooh Kim, 60, who underwent a liver transplant in 2024, pictured at their home on March 27, 2026.
Lian Pooh Kim, 60, who underwent a liver transplant in 2024, pictured at their home on March 27, 2026.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

Download the app

Get unlimited access to exclusive stories and incisive insights from the ST newsroom
Subscribe Placeholder
MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.